Accelerate Diagnostics, Inc. AXDX has secured FDA 510(k) clearance for its Accelerate Arc system and BC kit, designed for use with Bruker's MALDI Biotyper CA system (MBT-CA System) and MBT-CA ...
TUCSON, Ariz. – Accelerate Diagnostics, Inc. (NASDAQ:AXDX), a company specializing in rapid in vitro diagnostics with a current market capitalization of $28 million, has announced the submission of ...
Power system failure analysis and diagnostics constitute a critical field within electrical engineering, addressing the reliability and safety of the complex networks that underpin modern society. In ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する